Scarica l'app Stockscreener
136.04
1.09%
1.47
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$134.57
Aprire:
$134.7
Volume 24 ore:
11.53M
Relative Volume:
1.81
Capitalizzazione di mercato:
$236.77B
Reddito:
$43.11B
Utile/perdita netta:
$13.94B
Rapporto P/E:
17.05
EPS:
7.98
Flusso di cassa netto:
$6.78B
1 W Prestazione:
+1.73%
1M Prestazione:
+3.65%
6M Prestazione:
+6.77%
1 anno Prestazione:
+19.18%
Intervallo 1D:
$133.72
$136.73
Intervallo di 1 settimana:
$130.96
$136.73
Portata 52W:
$110.86
$140.84
Abbott Laboratories Stock (ABT) Company Profile
Nome
Abbott Laboratories
Settore
Industria
Telefono
(224) 667-6100
Indirizzo
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Confronta ABT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
136.04 | 234.21B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
97.83 | 145.55B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
376.83 | 144.45B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.08 | 122.61B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
74.41 | 43.77B | 5.69B | 1.41B | 577.90M | 6.95 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-18 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-06-16 | Iniziato | Leerink Partners | Market Perform |
| 2024-10-08 | Iniziato | Oppenheimer | Outperform |
| 2024-09-19 | Iniziato | Piper Sandler | Overweight |
| 2024-07-30 | Downgrade | Edward Jones | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2023-07-21 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | Reiterato | Barclays | Overweight |
| 2023-04-20 | Reiterato | Bernstein | Outperform |
| 2023-04-20 | Reiterato | JP Morgan | Overweight |
| 2023-04-20 | Reiterato | Raymond James | Outperform |
| 2023-04-20 | Reiterato | UBS | Buy |
| 2023-04-20 | Reiterato | Wolfe Research | Underperform |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-10-26 | Iniziato | Mizuho | Neutral |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-06 | Iniziato | Wolfe Research | Underperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-27 | Reiterato | Credit Suisse | Outperform |
| 2022-01-27 | Reiterato | Morgan Stanley | Overweight |
| 2022-01-27 | Reiterato | Raymond James | Outperform |
| 2022-01-27 | Reiterato | UBS | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-10-27 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | Iniziato | Redburn | Neutral |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Neutral |
| 2021-01-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-06-01 | Downgrade | Goldman | Neutral → Sell |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Neutral |
| 2020-01-02 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-06-13 | Reiterato | BofA/Merrill | Buy |
| 2019-02-07 | Reiterato | BofA/Merrill | Buy |
| 2019-01-02 | Downgrade | Citigroup | Neutral → Sell |
| 2018-11-30 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-01-30 | Reiterato | Citigroup | Neutral |
| 2018-01-25 | Reiterato | Stifel | Buy |
| 2018-01-25 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2018-01-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-01-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-10-19 | Reiterato | Stifel | Buy |
Mostra tutto
Abbott Laboratories Borsa (ABT) Ultime notizie
Abbott Laboratories Declares Quarterly Dividend of $0.59 (NYSE:ABT) - MarketBeat
Livforsakringsbolaget Skandia Omsesidigt Buys 6,300 Shares of Abbott Laboratories $ABT - MarketBeat
Elk River Wealth Management LLC Purchases New Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Position Increased by IFM Investors Pty Ltd - MarketBeat
Legacy Financial Strategies LLC Sells 1,925 Shares of Abbott Laboratories $ABT - MarketBeat
Assenagon Asset Management S.A. Acquires 33,224 Shares of Abbott Laboratories $ABT - MarketBeat
Security National Bank Acquires 14,430 Shares of Abbott Laboratories $ABT - MarketBeat
Worth Asset Management LLC Sells 9,491 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott warns of package-induced damage of ablation catheters - Medical Device Network
Precision Trading with Abbott Laboratories (ABT) Risk Zones - news.stocktradersdaily.com
Abbott declares 59 cent quarterly dividend, marking 407th consecutive payout By Investing.com - Investing.com Canada
Abbott Laboratories (NYSE:ABT) Shares Unloaded Rep. Julie Johnson - MarketBeat
FDA posts early alert about Abbott’s Tactiflex Ablation Catheter - MedTech Dive
Abbott Laboratories (ABT) Maintains Quarterly Dividend at $0.59 - GuruFocus
Abbott Laboratories Keeps Quarterly Dividend at $0.59 a Share, Payable Nov. 17 to Shareholders as of Oct. 15 - MarketScreener
Abbott Declares 407th Consecutive Quarterly Dividend, Payable on November 17, 2025 - MarketScreener
Abbott declares 59 cent quarterly dividend, marking 407th consecutive payout - Investing.com
Carcinoembryonic Antigen Market Size to Reach Around US$ 3.45 Billion By 2033, Driven by Growing Cancer Burden and Personalized Medicine | S&S Insider - GlobeNewswire Inc.
Abbott Laboratories $ABT Shares Bought by Mogy Joel R Investment Counsel Inc. - MarketBeat
Exchange Traded Concepts LLC Acquires 102,734 Shares of Abbott Laboratories $ABT - MarketBeat
Marshall Financial Group LLC Makes New Investment in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by Fulton Bank N.A. - MarketBeat
Waypoint Wealth Partners Inc. Purchases Shares of 1,983 Abbott Laboratories $ABT - MarketBeat
Family Legacy Financial Solutions LLC Takes $331,000 Position in Abbott Laboratories $ABT - MarketBeat
Wealth Enhancement Advisory Services LLC Has $179.89 Million Stock Position in Abbott Laboratories $ABT - MarketBeat
Bath Savings Trust Co Has $22.97 Million Holdings in Abbott Laboratories $ABT - MarketBeat
Mn Services Vermogensbeheer B.V. Raises Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Swedbank AB Sells 14,006 Shares of Abbott Laboratories $ABT - MarketBeat
Tompkins Financial Corp Cuts Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Secure Asset Management LLC Sells 5,288 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Stake Boosted by Alecta Tjanstepension Omsesidigt - MarketBeat
Abbott Laboratories $ABT Shares Acquired by Sumitomo Mitsui DS Asset Management Company Ltd - MarketBeat
ARS Wealth Advisors Group LLC Takes Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by Baader Bank Aktiengesellschaft - MarketBeat
Czech National Bank Acquires 26,900 Shares of Abbott Laboratories $ABT - MarketBeat
Is it the Right Time to Retain Abbott Stock in Your Portfolio? - sharewise.com
Abbott warns EP labs the tip can detach from its TactiFlex ablation catheters - Cardiovascular Business
Abbott warns on potential for tip damage with TactiFlex ablation catheter - MassDevice
Stokes Capital Advisors LLC Reduces Holdings in Abbott Laboratories $ABT - MarketBeat
Procyon Advisors LLC Cuts Stake in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by Gateway Investment Advisers LLC - MarketBeat
Pallas Capital Advisors LLC Acquires 2,007 Shares of Abbott Laboratories $ABT - MarketBeat
StrongBox Wealth LLC Acquires 3,011 Shares of Abbott Laboratories $ABT - MarketBeat
Divergent Planning LLC Purchases Shares of 29,653 Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Acquired by Dynamic Advisor Solutions LLC - MarketBeat
Abbott Laboratories $ABT Shares Acquired by Inspirion Wealth Advisors LLC - MarketBeat
Balefire LLC Increases Holdings in Abbott Laboratories $ABT - MarketBeat
Voya Investment Management LLC Trims Position in Abbott Laboratories $ABT - MarketBeat
Gradient Investments LLC Acquires 7,680 Shares of Abbott Laboratories $ABT - MarketBeat
How Abbott Laboratories (ABT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Abbott Laboratories poised to end in red after six-session rally - MSN
Abbott Laboratories Azioni (ABT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.41%
1.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):